I, D. L., F, D. C., J, B., AR, D., IP, C., MÁ, G., . . . O, C. (2024). Profiling and assessing the risks of image- and performance-enhancing drugs use during the COVID-19 lockdown. Frontiers in public health, 12, 1386721. https://doi.org/10.3389/fpubh.2024.1386721
Chicago Style (17th ed.) CitationI, De Luca, et al. "Profiling and Assessing the Risks of Image- and Performance-enhancing Drugs Use During the COVID-19 Lockdown." Frontiers in Public Health 12 (2024): 1386721. https://doi.org/10.3389/fpubh.2024.1386721.
MLA (9th ed.) CitationI, De Luca, et al. "Profiling and Assessing the Risks of Image- and Performance-enhancing Drugs Use During the COVID-19 Lockdown." Frontiers in Public Health, vol. 12, 2024, p. 1386721, https://doi.org/10.3389/fpubh.2024.1386721.